Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Padam C. Jain is active.

Publication


Featured researches published by Padam C. Jain.


European Journal of Pharmacology | 1979

Neuroleptic receptors: stereoselectivity for neuroleptic enantiomers.

Philip Seeman; Karen Westman; Miroslav Protiva; Jiri Jilek; Padam C. Jain; Anil K. Saxena; Nitya Anand; Leslie G. Humber; Adolf H. Philipp

In order to identify a pair of neuroleptic enantiomers with the highest stereoselective interaction with neuroleptic/dopamine receptors, the effects of eight pairs of neuroleptic enantiomers were tested on the specific binding of 3H-spiperone to crude homogenates of calf caudate nucleus. The ratios of the Ki values were: (+)-butaclamol/(-)-butaclamol = 3000; dexclamol/(-)-analogue = 151; (+)-isobutaclamol/(-)-isobutaclamol = 146; (-)-CTC/(+)-CTC= 109; (-)-centbutindole/(+)-centbutindole = 20; S(+)-octoclothepin/R(-)-octoclothepin = 11. Thus, the neuroleptic receptor is highly stereoselective for the rigid butaclamol derivatives, but much less so for the flexible neuroleptics. The 3H-apomorphine binding site, however, had a stereoselectivity ratio of only 7 for isobutaclamol, further suggesting that the high affinity sites (i.e. nM) for 3H-neuroleptic binding and for 3H-apomorphine binding are different.


Progress in drug research | 1977

Agents acting on central dopamine receptors.

Naresh Kumar; Padam C. Jain

Dopamine was long believed to be only of functional significance as a precursor of epinephrine and norepinephrine. It became a focus of interest only after Carlsson’s [1] demonstration of its presence in relatively high concentrations in various parts of the brain, mainly striatum [2] and inner retina [3]. Since then there is a growing evidence of the involvement of dopamine as an important neurotransmitter and of the clinical significance of dopaminergic transmission in CNS. It has been suggested that degeneration of the dopaminergic pathway that connects substantia nigra to the caudate nucleus and putamen is a primary feature in the etiology of Parkinson’s disease [4, 5]. Similarly, dopaminergic system has been implicated in the treatment of schizophrenia with antipsychotic drugs [6]. Dopamine agonists and antagonists are thus antiparkinsonian and antipsychotic drugs, respectively, due to their action on central dopamine receptors [7].


Journal of The Chemical Society D: Chemical Communications | 1971

Effect of substituents on the stereochemical course of Diels–Alder reaction between β-nitrostyrenes and trans,trans-1,4-diphenylbutadiene

Padam C. Jain; Yatindra N. Mukerjee; Nitya Anand

In a study of the Diels–Alder reaction of trans,-trans-1,4-diphenylbutadiene with β-nitrostyrenes a marked stereoselectivity to phenyl “endo” adducts has been observed on introduction of electron-withdrawing substituents in the para-position of the phenyl ring of the β-nitrostyrenes.


Journal of Medicinal Chemistry | 1968

Chemical and pharmacological investigations of some omega substituted alkylamino-3-aminopyridines

Padam C. Jain; V. Kapoor; Nitya Anand; G. K. Patnaik; Allauddin Ahmad; Man M. Vohra


Journal of Medicinal Chemistry | 1973

Agents acting on the central nervous system. 15. 2-Substituted 1,2,3,4,6,7,12,12a-octahydropyrazino [2',1':6,1]pyrido[3,4-b]indoles. New class of central nervous system depressants

Anil K. Saxena; Padam C. Jain; Nitya Anand; P. R. Dua


Synthesis | 1976

A Novel Synthesis of Substituted 2-Oxopiperidines

H. Bhagwatheeswaran; S. P. Gaur; Padam C. Jain


Journal of Medicinal Chemistry | 1970

Agents acting on the central nervous system. XIII. 2,3,4,4a,5,6-hexahydro-1(H)-pyrazino[1,2-a]quinolines. A new class of hypotensive agents

V. Aruna Rao; Padam C. Jain; Nitya Anand; R. C. Srimal; P. R. Dua


Journal of the American Chemical Society | 1974

Novel aspects of the Diels-Alder reaction with 1,4-and 1,2-diphenylbutadienes under thermal and Lewis acid catalyzed conditions

Padam C. Jain; Yatindra N. Mukerjee; Nitya Anand


Bioorganic & Medicinal Chemistry | 2003

QSAR studies in substituted 1,2,3,4,6,7,12,12a-octa-hydropyrazino[2′,1′:6,1]pyrido[3,4-b]indoles—a potent class of neuroleptics☆

Anil K. Saxena; Siya Ram; Mridula Saxena; Nidhi Singh; Philip Prathipati; Padam C. Jain; Hemant K. Singh; Nitya Anand


Archiv Der Pharmazie | 1984

Syntheses and Biological Activities of 1,4-Disubstituted Piperidines

Krishna A. Gupta; Anil K. Saxena; Padam C. Jain; Nitya Anand

Collaboration


Dive into the Padam C. Jain's collaboration.

Top Co-Authors

Avatar

Nitya Anand

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Anil K. Saxena

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

P. R. Dua

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

R. C. Srimal

Indian Institute of Toxicology Research

View shared research outputs
Top Co-Authors

Avatar

Naresh Kumar

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar

Dhawan Bn

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

G. K. Patnaik

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

Hemant K. Singh

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Krishna A. Gupta

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Man M. Vohra

Central Drug Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge